E-LIB Suche - Ergebnisse für: Burgoon, Lyle D

1

The physiological and biochemical basis of potency threshol..:

Borgert, Christopher J. ; Burgoon, Lyle D. ; Matthews, John C.
Archives of Toxicology. 98 (2024) 6 - p. 1795-1807 , 2024

Link: https://doi.org/10.1007/..

2

The database makes the poison: How the selection of dataset..:

Burgoon, Lyle D. ; Kluxen, Felix M. ; Hüser, Anja.
Regulatory Toxicology and Pharmacology. 151 (2024) - p. 105663 , 2024

Link: https://doi.org/10.1016/..

3

Kinetically-derived maximal dose (KMD) indicates lack of hu..:

Burgoon, Lyle D. ; Borgert, Christopher J. ; Fuentes, Claudio.
Archives of Toxicology. 98 (2023) 1 - p. 327-334 , 2023

Link: https://doi.org/10.1007/..

4

Understanding and overcoming the technical challenges in us..:

Burgoon, Lyle D. ; Kluxen, Felix M. ; Frericks, Markus
Regulatory Toxicology and Pharmacology. 137 (2023) - p. 105311 , 2023

Link: https://doi.org/10.1016/..

5

Range of the perfluorooctanoate (PFOA) safe dose for human ..:

Burgoon, Lyle D. ; Clewell, Harvey J. ; Cox, Tony...
Regulatory Toxicology and Pharmacology. 145 (2023) - p. 105502 , 2023

Link: https://doi.org/10.1016/..

6

A novel approach to calculating the kinetically derived max..:

Burgoon, Lyle D. ; Fuentes, Claudio ; Borgert, Christopher J.
Archives of Toxicology. 96 (2022) 3 - p. 809-816 , 2022

Link: https://doi.org/10.1007/..

7

Progress towards an OECD reporting framework for transcript..:

Harrill, Joshua A. ; Viant, Mark R. ; Yauk, Carole L....
Regulatory Toxicology and Pharmacology. 125 (2021) - p. 105020 , 2021

Link: https://doi.org/10.1016/..

8

Assessment of Transcriptomic and Apical Responses ofDaphnia..:

Coady, Katherine K. ; Burgoon, Lyle ; Doskey, Claire.
Environmental Toxicology and Chemistry. 39 (2020) 8 - p. 1578-1589 , 2020

Link: https://doi.org/10.1002/..

9

Organizing mechanism-related information on chemical intera..:

Price, Paul S. ; Jarabek, Annie M. ; Burgoon, Lyle D.
Environment International. 138 (2020) - p. 105673 , 2020

Link: https://doi.org/10.1016/..

10

Development of Adverse Outcome Pathway for PPARγ Antagonism..:

Jeong, Jaeseong ; Garcia-Reyero, Natalia ; Burgoon, Lyle...
Chemical Research in Toxicology. 32 (2019) 6 - p. 1212-1222 , 2019

Link: https://doi.org/10.1021/..

11

Predicting the Probability that a Chemical Causes Steatosis..:

Burgoon, Lyle D. ; Angrish, Michelle ; Garcia‐Reyero, Natalia...
Risk Analysis. 40 (2019) 3 - p. 512-523 , 2019

Link: https://doi.org/10.1111/..

12

Adverse Outcome Pathway on antagonist binding to PPARα lead..

OECD Series on Adverse Outcome Pathways, no.10

Gust, Kurt A ; Wilbanks, Mitchell S ; Collier, Zachary A.. , 2019

Link: https://doi.org/10.1787/..

13

Different as night and day: Behavioural and life history re..:

Gust, Kurt A. ; Kennedy, Alan J. ; Laird, Jennifer G....
Molecular Ecology. 28 (2019) 19 - p. 4422-4438 , 2019

Link: https://doi.org/10.1111/..

14

Building and Applying Quantitative Adverse Outcome Pathway ..:

Perkins, Edward J. ; Ashauer, Roman ; Burgoon, Lyle...
Environmental Toxicology and Chemistry. 38 (2019) 9 - p. 1850-1865 , 2019

Link: https://doi.org/10.1002/..

15

An AOP-based ontology for spina bifida caused by disturbanc..:

Piersma, Aldert H. ; Baker, Nancy C. ; Burgoon, Lyle D....
Reproductive Toxicology. 80 (2018) - p. 20 , 2018

Link: https://doi.org/10.1016/..